NRG R0920

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Head and Neck



A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

Eligible for screening study DCP 001


R0920 is closed to accrual as of 5 PM ET Tuesday, March 27, 2018, because it has reached its accrual target.

Leave a Reply